Daily Stock List
Vitality Biopharma, Inc. (VBIO)
SmallCap Network, Stock Beast, and Promotion Stock Secrets reported earlier on Vitality Biopharma, Inc. (VBIO), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Vitality Biopharma, Inc.’s dedication is to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. Since 2012, the Company has developed a unique capability for the production of molecules through glycosylation, a form of enzymatic biosynthesis that was originally developed to improve the taste of stevia, a high-potency sweetener. The platform is well suited for the discovery of new pharmaceutical products. Vitality Biopharma is based in Los Angeles, California.
Late in 2015, Vitality Biopharma successfully modified cannabidiol (CBD), which is not psychoactive, and in continuing work has created a novel class of pharmaceuticals known as cannabosides. Cannabosides, upon ingestion can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. Site-specific delivery could enable oral drug formulations of cannabinoids to provide therapeutic benefits. This is while decreasing or avoiding the systemic delivery of THC into the bloodstream.
The Company can biosynthesize cannabinoid glycosides (cannabosides) via enzyme biosynthesis. Vitality Biopharma is one of only a very few groups around the world who
know how to produce and work with the enzymes that perform glycosylation. It has been centered on it because the same enzymes are used to modify the taste of the above-mentioned stevia (steviol glycosides).
Last month, Vitality Biopharma announced the filing of a global Patent Cooperation Treaty (PCT) patent application. This represents a milestone in the Company’s development of a platform of cannabinoid pharmaceuticals. The PCT is an international patent law treaty that provides a unified procedure for filing patent applications to protect inventions in each of its member states.
Vitality Biopharma's patent filing includes details, which were beforehand submitted in three separate U.S. provisional applications, and includes 79 patent claims and nearly 200 individual compounds, including novel glycoside prodrugs of the most abundant phytocannabinoids, THC and cannabidiol (CBD), and an array of other phytocannabinoids and endocannabinoids. Furthermore, in November, the Company announced that it is advancing its cannabosides pharmaceuticals for the treatment of narcotic bowel syndrome. This is a severe form of opiate-induced abdominal pain.
Vitality Biopharma, Inc. (VBIO), closed Thursday's trading session at $1.385, up 3.36%, on 269,518 volume with 331 trades. The average volume for the last 60 days is 197,277 and the stock's 52-week low/high is $0.30/$2.25.
Weyland Tech, Inc. (WEYL)
DreamTeamNetwork, Wall Street Mover, and OTCJournal reported earlier on Weyland Tech, Inc. (WEYL), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Weyland Tech, Inc. is a provider of mobile business applications. The focus of the Company’s CreateApp platform is on the Asia markets. Currently, Weyland Tech offers the CreateApp platform directly in Singapore, India (Jaipur), and the U.S.A. and Canada. Weyland Tech is based in Hong Kong. The Company’s shares trade on the OTC Markets Group’s OTCQB.
Weyland Tech’s CreateApp platform is offered in 12 languages. It enables small-medium-sized businesses (SMB's) to create a mobile application (APP) without the requirement of technical knowledge and background. As a result, SMB's can build sales, reach more customers, and promote their products and services through a simple, easy-to-build mobile APP. They can do so in an affordable and cost-effective manner.
Weyland Tech presently offers a DIY (Do-it-Yourself) App builder through a 'white label' platform. It offers this by way of strategic partnerships in the EU (minus Russia, Turkey, Armenia, Azerbaijan); Malaysia; Hong Kong/South China; Indonesia; and North/Central/South America. It will offer this in Korea via IAM, Inc. (www.createapp.kr).
Weyland Tech has entered into a Memorandum of Understanding (MOU) with 2C2P, the top Southeast Asian payments services company. 2C2P and Weyland Tech will work together on a Mobile Commerce (m-commerce) solution, which enables SMB’s to provide multi-payment options to consumers in the Southeast Asia region.
Weyland Tech also signed a Master Service Agreement (MSA) with Orient Asia Pacific Limited (OAP). This is for the Indonesia market. OAP is a software and digital technology consulting enterprise. In September 2016, Weyland Tech announced that it signed a strategic licensing agreement with BGT Corporation Public Company Limited (BGT), for the Thai market.
Furthermore, in October, Weyland Tech announced that its Malaysian partner signed and launched a "white label" App. Called "MocaApp," this App centers on the Southeast Asian small-medium-sized businesses (SMB's) market. This month, Weyland Tech announced that it entered into a Strategic Partnership with DPEX Worldwide.
DPEX Worldwide in collaboration with the Company will together offer a Mobile Commerce (m-commerce) solution coupled to a logistics solution. DPEX Worldwide is a foremost provider of express and E-Commerce solutions in Asia.
Weyland Tech, Inc. (WEYL), closed Thursday's trading session at $4.59, up 6.74%, on 10,200 volume with 23 trades. The average volume for the last 60 days is 5,767 and the stock's 52-week low/high is $0.30/$5.10.
BioRestorative Therapies, Inc. (BRTX)
Streetwise Reports, Investor Ideas, and ProActive Capital reported earlier on BioRestorative Therapies, Inc. (BRTX), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
BioRestorative Therapies, Inc. is a life sciences company focusing on adult stem cell-based therapies for different personal medical applications. The OTCQB-listed Company develops products and medical procedures using cell and tissue protocols, largely involving adult stem cells. BioRestorative Therapies’ corporate, administrative and laboratory operations are in Melville, New York.
The Company’s aim is to become a leader in providing medical procedures utilizing cell and tissue protocols, mainly involving adult stem cells (non-embryonic), and allowing patients to undergo minimally invasive cellular-based treatments. Its products and medical procedures include brtxDISC™ (Disc Implanted Stem Cells), its Disc/Spine Program, and ThermoStem®, its Metabolic Program.
Its brtxDISC™ is an investigational non-surgical treatment for bulging and herniated lumbar discs. brtxDISC™’s intention is for patients who have failed non-invasive procedures and face the prospect of surgery. BioRestorative Therapies’ lead cell therapy candidate is BRTX-100. This product is formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow.
ThermoStem® is a treatment employing brown fat stem cells. ThermoStem® is under development for metabolic disorders. This includes diabetes and obesity. The Company is developing a cell-based therapy to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). The intention of BAT is to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans.
BioRestorative Therapies is the beneficiary of a patent granted for a licensed curved needle device (CND). The design of it is to deliver cells and/or other therapeutic products or material to a site having damage in need of facilitated repair. The Company’s intention is to advance the design of this curved needle device to facilitate the delivery of substances, including living cells, to specific locations within the body and reduce the potential for damage to neighboring structures.
In September 2016, BioRestorative Therapies announced that the Journal of Translational Medicine published the results of a long-term safety and feasibility study of the injection of autologous, hypoxic cultured mesenchymal stem cells (MSCs) into patients with chronic lumbar degenerative disc disease related to protruding/bulging discs. BioRestorative Therapies is preparing for an Investigational New Drug (IND) submission with the FDA to seek clearance to begin a clinical trial using its lead therapy candidate, BRTX-100, which consists of hypoxic cultured MSCs to treat chronic lower back pain because of degenerative disc disease related to protruding/bulging discs.
Per the publication, early human clinical data suggests safety and feasibility for the clinical use of hypoxic cultured bone marrow-derived mesenchymal stem cells for the treatment of lower back pain because of degenerative disc disorder.
BioRestorative Therapies, Inc. (BRTX), closed Thursday's trading session at $3.15, even for the day. The average volume for the last 60 days is 1,726 and the stock's 52-week low/high is $2.61/$4.65.
OXIS International, Inc. (OXIS)
Money Morning, TopPennyStockMovers, Marketbeat.com, Cannabis Financial Network News, Gryphon Digest, and PennyStocks24 reported earlier on OXIS International, Inc. (OXIS), and we report on the Company today, here at the QualityStocks Daily Newsletter.
OXIS International, Inc. is a developer of innovative drugs focused on the treatment of cancer and other unmet medical needs. The Company’s drug candidate, OXS-2175, is a small molecule therapeutic candidate targeting the treatment of triple-negative breast cancer (TNBC). In in vitro and in vivo models of TNBC, OXS-2175 demonstrated the ability to inhibit metastasis. OXIS is targeting multiple myeloma, triple-negative breast cancer, non-Hodgkin's lymphoma, and more with highly potent biopharmaceutical drugs designed for targeted therapy. Oxis Biotech, Inc. is a wholly-owned subsidiary of Oxis International (Tampa, Florida).
The Company’s lead drug candidate, OXS-1550 (DT2219ARL), is a novel bispecific scFv recombinant fusion protein-drug conjugate. It consists of the variable regions of the heavy and light chains of anti-CD19 and anti-CD22 antibodies and a modified form of diphtheria toxin as its cytotoxic drug payload. OXS-1550 at the same time targets cancer cells expressing the CD19 receptor or CD22 receptor or both receptors.
When OXS-1550 binds to cancer cells, the cancer cells internalize OXS-1550 and are killed because of the action of the drug's cytotoxic payload. OXS-1550 has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia. Oxis Biotech earlier executed an exclusive international license agreement to further develop and commercialize OXS-1550.
The Company’s OXS-4235 is a small molecule therapeutic candidate. It targets the treatment of multiple myeloma and associated osteolytic lesions. In in vitro and in vivo models of multiple myeloma and osteoporosis, OXS-4235 demonstrated the ability to kill multiple myeloma cells, and decrease osteolytic lesions in bone.
Oxis Biotech is continuing to concentrate on a cure for the Zika virus. On March 1, 2016, Oxis disclosed that Dr. Sean Xie identified small molecule chemical inhibitors, which target non-structural proteins "with the potential for blocking Zika virus replication." Dr. Xie is a research scientist, professor of pharmacology at the University of Pittsburgh and a member of Oxis' Scientific Advisory Board.
Oxis Biotech announced in August 2016 that its research partners at the University of Minnesota cancer center are working together with the National Institutes of Health to hasten commercialization of its promising TriKE cancer-fighting platform. Earlier, Oxis announced that it agreed to a major partnership with the University of Minnesota to develop and commercialize cancer therapies using TriKE technology developed by researchers at the university.
OXIX International’s Scientific Advisors include the above-mentioned Xiang-Qun (Sean) Xie, MD, PHD, EMBA; Cassian Yee, M.D; Dr. Lisa A. Haile, PH.D; and Dr. Stephen M. Chang, PH.D. The Company’s Business Advisory Board includes Mr. Michael S. Sitrick. Mr. Sitrick is a former board member of APP Pharmaceuticals Company and Abraxis BioScience. He is the Founder, Chairman and Chief Executive Officer (CEO) of Sitrick And Company, a globally recognized strategic communications firm.
OXIS International, Inc. (OXIS), closed Thursday's trading session at $0.102, up 2.00%, on 38,106 volume with 23 trades. The average volume for the last 60 days is 205,907 and the stock's 52-week low/high is $0.08/$6.00.
Aftermaster, Inc. (AFTM)
Wall Street Mover, Equities, and TopPennyStockMovers reported earlier on Aftermaster, Inc. (AFTM), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.
Aftermaster, Inc. is an industry leading audio technology enterprise. Aftermaster is a pioneering audio technology originally developed for the mastering, re-mastering, and processing of audio through Aftermaster HD Audio Labs, Inc. The Company’s executive team includes music and audio technology leaders Justin Timberlake, Rodney "Darkchild" Jerkins, Pete Doell, Andrew Wuepper, Shelly Yakus, and Larry Ryckman. Aftermaster has its corporate headquarters in Hollywood, California.
Aftermaster delivers a consummate clarity, depth, and fullness to audio recordings. It does so while delivering a considerable increase in volume without increased distortion or loss of dynamic range. The technology has been used by a number of top musicians looking to create a fuller and richer sound quality than otherwise available in digital audio.
Aftermaster’s ProMaster HD will be available on Adobe® Audition® CC, a professional audio workstation for mixing, finishing and editing. ProMaster HD is the Company’s online audio mastering service.
The integration of ProMaster HD enables Adobe Audition CC users to immediately master their original work directly within Adobe Creative Cloud®. ProMaster HD instils the clearest, deepest sound quality into any recording. This raises that audio to a studio remastered sound experience.
Earlier this year, Aftermaster announced a new partnership with premier independent digital music distribution and publishing administration service, TuneCore. With this agreement, Aftermaster will serve as TuneCore's new professional mastering service, enabling and empowering users with direct access to award-winning senior mastering engineers in Aftermaster's state-of-the-art facilities.
This past October, Aftermaster announced the beginning of production on its new Aftermaster Pro. This is the world's first personal re-mastering device. The Aftermaster Pro masters and re-masters inconsistent sound in real-time.
Aftermaster Pro is easily installed by way of HDMI cables between any TV and the A/V source (cable or satellite box, and more). Additionally, the portable device is equipped with a rechargeable battery and 1/8" audio ports. Therefore, it can be used on-the-go to significantly improve the audio of smartphones, tablets, computers, and any audio-enabled device. Aftermaster Pro is manufactured in the United States.
Aftermaster, Inc. (AFTM), closed Thursday's trading session at $0.40, up 2.56%, on 36,342 volume with 16 trades. The average volume for the last 60 days is 76,425 and the stock's 52-week low/high is $0.26/$0.55.
eXp World Holdings, Inc. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $4.26, off by 2.07%, on 3,296 volume with 12 trades. The stock’s average daily volume over the past 60 days is 22,482, and its 52-week low/high is $0.6101/$5.84.
eXp World Holdings Inc., the holding company for eXp Realty LLC, The Agent-Owned Cloud Brokerage®, has retained MZ Group as its investor relations advisor. MZ Group will assist and advise eXp World Holdings with communicating its corporate, financial, and investor developments to shareholders, and assisting the Company with building its public brand and investor base.
eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp World Holdings, Inc. Company Blog
eXp World Holdings, Inc. News:
eXp World Holdings, Inc. Retains MZ Group as its Investor Relations Advisor
eXp Realty named the Number 2 Best Small Business Workplace in Oklahoma
Marsee Wilhems Team Joins eXp Realty in Tucson
National Waste Management Holdings, Inc. (NWMH)
The QualityStocks Daily Newsletter would like to spotlight National Waste Management Holdings, Inc. (NWMH). Today, National Waste Management Holdings, Inc. closed trading at $0.06555, up 9.07%, on 16,110 volume with 5 trades. The stock’s average daily volume over the past 60 days is 13,781, and its 52-week low/high is $0.06/$1.52.
National Waste Management Holdings, Inc. (NWMH) is a solid waste management company offering comprehensive solutions for full waste diversion along Florida's west coast and in upstate New York. With an established base of long-term partnerships with municipal, institutional, commercial and industrial customers, along with a successful acquisition strategy, National Waste has set its course to become a leading waste diversion company.
National Waste's 54-acre landfill facility located in Hernando, Florida, handles annual average disposals of roughly 240,000 cubic yards of construction debris annually. The site also offers an array of ancillary services such as roll-off dumpster services, mulching services and recycling. While the landfill facility is already permitted for future expansion, National Waste's growth strategy also calls for the opening of new satellite offices in counties and states that neighbor its existing operations.
In addition to increasing its geographic foothold, National Waste employs a strategic acquisition model to increase its overall market share. In 2015, the company acquired Gateway Rolloff Services LP and Waste Recovery Enterprises LLC, which are expected to generate a combined $3.8 million in annual revenue for National Waste moving forward. In the second quarter of 2016, National Waste added Sivart Services to its roster, creating an immediate source of additional revenue and expanding its foothold in the northeast area of New York.
Management has confirmed its interest in additional acquisition targets while demonstrating its ability to effectively integrate and organically grow the company's existing acquisition companies and maintain efficient operations. Disclaimer
National Waste Management Holdings, Inc. Company Blog
National Waste Management Holdings, Inc. News:
NetworkNewsWire Releases Exclusive Audio Interview with National Waste Management Holdings, Inc. (NWMH)
National Waste Management Holdings, Inc. (NWMH) Engages NetworkNewsWire for Corporate Communications Solutions
National Waste Management Holdings Inc. Reports 269% Increase in Third-Quarter Revenue
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.0014, even for the day, on 28,448,305 volume with 45 trades. The stock’s average daily volume over the past 60 days is 16,130,413 and its 52-week low/high is $0.001/$0.058.
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Continues Discussions with Madagascar for Energy Projects
Dominovas Energy Secures Gas Supply for South Africa
Dominovas Energy Dispatches Watkins to Meet With Gas Supplier
OurPet's Company (OPCO)
The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $0.98, even for the day. The stock’s average daily volume over the past 60 days is 5,022, and its 52-week low/high is $0.6882/$1.06.
OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.
In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.
The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.
OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer
OurPet's Company Company Blog
OurPet's Company News:
OurPets(R) Switchgrass Natural Cat Litter(TM) Wins Pet Business 2016 Industry Recognition Award
OurPet's Company to Webcast, Live, at VirtualInvestorConferences December 1
OurPetís Company Reports Record Third Quarter 2016 Results
GainClients, Inc. (GCLT)
The QualityStocks Daily Newsletter would like to spotlight GainClients, Inc. (GCLT). Today, GainClients, Inc. closed trading at $0.04, off by 11.11%, on 20,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 175,673, and its 52-week low/high is $0.01/$0.20.
GainClients, Inc. (GCLT) is a software service company focused primarily on the development of marketing services for real estate professionals and valuable home search and area information tools for consumers. The company's innovations expound the popularity of online networks by helping real estate professionals better serve their clients through the sharing of accurate real estate data.
The company's main product is the GCard progressive networking system, which is designed to build and promote relationships among real estate professionals and their clients. Using the GCard, agents and brokers have the means to offer real estate, lending and title services information through an integrated, web-based network, capitalizing on the ongoing shift in consumer preference toward mobile solutions.
Similar to the features of other popular online networks, professional users can invite clients and their industry partners to join their GCard networks and be featured as trusted team members. From here, the teams can quickly provide real estate, lending and title services and information to consumers via smartphone and web. With better communication throughout the process of buying or selling homes, purchases can move more quickly and more comfortably to completion.
Strategic partnerships are an important component of GainClients' growth strategy. The company recently established a worldwide licensing arrangement with CLOVIS LLC, a partnership that will enable the distribution of both companies' proprietary technologies to the real estate industry. CLOVIS will use GainClients' GCard to develop a unique lead generation program for the broader real estate marketing and advertising industry.
GainClients also offers GCHomeSearch, its stand-alone website that provides non-real estate customers, such as lenders and title professionals, with accurate listing data, historical property data, neighborhood information and demographics. When used with the GCard, the user is also privy to loan payment calculators, loan rates, closing cost estimators and other tools needed to make intelligent buying and selling choices. Disclaimer
GainClients, Inc. Company Blog
GainClients, Inc. News:
GainClients, Inc. Retains Largest Real Estate Customer on its GCard Service
GainClients, Inc. Announces Corporate Update
GainClients, Inc. Enters Into A Licensing Agreement with Real Estate Technology Upstart CLOVIS, LLC To Expand Its Technology Platform
Today's Top 3
Small Cap Firm
Penny Stock 101
The QualityStocks Public Company Sponsor News